Improving Predictability and Transparency in DEA and FDA Regulation

Improving Predictability and Transparency in DEA and FDA Regulation

Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, Second Session, April 7, 2014

Website or Online Data - 2015
Rate this:
Publisher: Washington : U.S. Government Publishing Office, 2015.
Characteristics: 1 online resource (iv, 217 pages)

Related Resources


Opinion

From the critics


Community Activity

Comment

Add a Comment

There are no comments for this title yet.

Age

Add Age Suitability

There are no ages for this title yet.

Summary

Add a Summary

There are no summaries for this title yet.

Notices

Add Notices

There are no notices for this title yet.

Quotes

Add a Quote

There are no quotes for this title yet.

Explore Further

Subject Headings

  Loading...

Find it at CPL

  Loading...
[]
[]
To Top